Versant Capital Management, Inc Acadia Pharmaceuticals Inc Transaction History

Versant Capital Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$17.8 - $25.65 $427 - $615	24 New	24 $0
Q3 2022 Dec 30, 2022	BUY	$14.11 - $18.27 $691 - $895	49 New	49 $1,000
Q4 2021 Jan 06, 2022	SELL	$16.79 - $27.09 $369 - $595	-22 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$15.78 - $24.77 $1,798 - $2,823	-114 Reduced 83.82%	22 $0
Q2 2021 Jul 22, 2021	BUY	$19.4 - $27.42 $2,638 - $3,729	136 New	136 $3,000
Q1 2021 Apr 27, 2021	SELL	$25.02 - $54.99 $775 - $1,704	-31 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$41.04 - $56.79 $246 - $340	-6 Reduced 16.22%	31 $1,000
Q1 2020 Apr 17, 2020	BUY	$31.65 - $46.87 $1,171 - $1,734	37 New	37 $1,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.